Arriving in the field of excess body fat therapy, retatrutide presents a distinct method. Unlike many existing medications, retatrutide works as a double agonist, concurrently targeting both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) sensors. This simultaneous activation promotes various beneficial effects, like be